Search results for "Anticoagulation"
Anticoagulation for heart failure and afib associated with reductions in mortality, but maybe not readmissions
Starting anticoagulation for older patients with heart failure and atrial fibrillation at hospital discharge was associated with improved mortality at 1 and 3 years but was not associated with improved rates of all-cause cardiovascular readmission or stroke, a study found.
https://immattersacp.org/weekly/archives/2014/09/16/6.htm
16 Sep 2014
Guidance released on use of new oral anticoagulants in nonvalvular afib
The European Heart Rhythm Association published guidance last week on using new oral anticoagulants in patients with nonvalvular atrial fibrillation.
https://immattersacp.org/weekly/archives/2013/05/07/6.htm
7 May 2013
NSAIDs may increase bleeding, CV events when combined with antiplatelet or anticoagulant agents post-MI
Nonsteroidal anti-inflammatory drugs (NSAIDs) were associated with increased risk of bleeding and thrombotic events, even during short-term treatment, among patients receiving antithrombotic therapy after myocardial infarction (MI), a study found.
https://immattersacp.org/weekly/archives/2015/03/03/2.htm
3 Mar 2015
New afib guideline covers novel anticoagulants, ablation
A new guideline for managing nonvalvular atrial fibrillation recommends using a more comprehensive risk calculator, diminishing aspirin's role, adding 3 new anticoagulants to treatment options, and increasing use of radiofrequency ablation.
https://immattersacp.org/weekly/archives/2014/04/01/4.htm
1 Apr 2014
Adding aspirin or NSAID to anticoagulant doubles bleeding risk
Taking aspirin or an NSAID while on anticoagulant therapy significantly increases the risk of bleeding in patients who have had a venous thromboembolism (VTE), a recent study found.
https://immattersacp.org/weekly/archives/2014/04/22/5.htm
22 Apr 2014
DOACs may be safe, effective for VTE prevention in patients with higher weight, BMI
Patients with first-time venous thromboembolism (VTE) who weighed 120 kg or more and had a body mass index (BMI) of 40 kg/m2 or more were not at higher risk for bleeding or recurrent VTE with direct-acting oral anticoagulants (DOACs) versus warfarin.
https://immattersacp.org/weekly/archives/2021/11/09/4.htm
9 Nov 2021
Higher CHADS2 scores can indicate higher risk in patients on anticoagulants
Higher CHADS2 scores pointed to higher risk for adverse outcomes, including stroke, bleeding and death, in patients with atrial fibrillation receiving anticoagulation, according to a new study.
https://immattersacp.org/weekly/archives/2011/11/15/5.htm
15 Nov 2011
Updated Beers criteria highlight medications that are risky in older patients
The American Geriatrics Society has added warfarin as a medication to avoid and urged caution with sodium-glucose cotransporter-2 inhibitors in the latest update of its guidance on prescribing for U.S. adults ages 65 years and older.
https://immattersacp.org/weekly/archives/2023/05/16/1.htm
16 May 2023
New-generation anticoagulants associated with bleeding after ACS in patients on antiplatelet therapy
New-generation anticoagulants are associated with increased bleeding risk when used after acute coronary syndrome (ACS) in patients taking antiplatelet agents, according to a new meta-analysis.
https://immattersacp.org/weekly/archives/2012/10/02/5.htm
2 Oct 2012
Use of warfarin down, DOACs up in commercially insured patients with cirrhosis, nonvalvular afib
While more than half of eligible patients with cirrhosis and concurrent nonvalvular atrial fibrillation did not receive anticoagulation between 2012 and 2019, use of direct oral anticoagulants (DOACs) increased substantially during that time, a recent study found.
https://immattersacp.org/weekly/archives/2023/01/17/4.htm
17 Jan 2023